Clinical Neuropathology, Volume 39 (2020) - July/August (171 - 178)

Intracranial chondromas: A histopathologic and molecular study of three cases
Arnault Tauziède-Espariat1, Fanny Burel-Vandenbos2, 3, Florence Pedeutour3, Albane Gareton1, Raphaël Saffroy4, Felipe Andreiuolo1, Thomas Blauwblomme5, Volodia Dangouloff-Ros6, Nathalie Boddaert6, Emmanuèle Lechapt1, Fabrice Chrétien1, Pascale Varlet1
1 GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital, Department of Neuropathology, Paris, 2 Pasteur I University Hospital, Central Laboratory of Pathology, 3 Centre Hospitalier Universitaire de Nice, Faculté de Médecine, Laboratory of Solid Tumors Genetics, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7  2  8  4 /INSERM U 1  0  8  1 , Université Côte d’Azur (UCA), Nice, 4 Paul Brousse Hospital, Department of Biochemistry and Oncogenetics, Villejuif, 5 Necker University Hospital, Department of Pediatric Neurosurgery, 6 Necker University Hospital, Department of Radiology, Paris, France

Add to Cart  

 

DOI 10.5414/NP301238

Abstract

Aims: Meningeal chondromas constitute a small fraction of central nervous system tumors, with only 61 cases reported in the literature. Somatic mutations of IDH1/2 genes have been described in enchondromas, and, in soft-tissue chondromas, rearrangements of the HMGA2 gene have been reported. The aim of our study was to perform molecular analyses of 3 additional cases and to do a complete review of the literature to better characterize this rare entity.
Materials and methods: Here, we report 3 cases of primitive meningeal chondromas in children and young adults. Immunohistochemical analyses for HMGA2 and IDH1R132H, molecular analyses of IDH1/2 mutations, and FISH analysis of the HMGA2 locus were performed.
Results: Immunohistochemical analyses of all cases were negative for IDH1R132H and HMGA2 proteins. Molecular analyses failed to reveal IDH1/2 mutations, and FISH analyses did not evidence any HMGA2 rearrangements. Similarly to what is reported in the literature, the 3 meningeal chondromas in this study were benign tumors with no recurrence after complete resection with a follow-up of 85, 46, and 89 months.
Conclusion: Meningeal chondroma is rare. It affects predominantly young adults and has a good outcome. No molecular alterations have currently been described in this entity.

Author Details

Authors

Departments

  • 1 GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital, Department of Neuropathology, Paris,
  • 2 Pasteur I University Hospital, Central Laboratory of Pathology,
  • 3 Centre Hospitalier Universitaire de Nice, Faculté de Médecine, Laboratory of Solid Tumors Genetics, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR
  • 7 
  • 2 
  • 8 
  • 4 /INSERM U
  • 1 
  • 0 
  • 8 
  • 1 , Université Côte d’Azur (UCA), Nice,
  • 4 Paul Brousse Hospital, Department of Biochemistry and Oncogenetics, Villejuif,
  • 5 Necker University Hospital, Department of Pediatric Neurosurgery,
  • 6 Necker University Hospital, Department of Radiology, Paris, France

Address

Arnault Tauziède-Espariat, MD
GHU Paris Psychiatrie Neurosciences
Sainte-Anne Hospital
Department of Neuropathology
1, Rue Cabanis, 75014 Paris
Email: [email protected]

Citation

Tauziède-Espariat A, Burel-Vandenbos F, Pedeutour F, Gareton A, Saffroy R, Andreiuolo F, Blauwblomme T, Dangouloff-Ros V, Boddaert N, Lechapt E, Chrétien F, Varlet P.Intracranial chondromas: A histopathologic and molecular study of three cases. Clin Neuropathol. 2020; 39: 171-178. doi: 10.5414/NP301238. Pubmed: https://pubmed.ncbi.nlm.nih.gov/31983386; PMID: 31983386.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart